3g4g
From Proteopedia
(Difference between revisions)
												
			
			| Line 1: | Line 1: | ||
==Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871==  | ==Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871==  | ||
| - | <StructureSection load='3g4g' size='340' side='right' caption='[[3g4g]], [[Resolution|resolution]] 2.30Å' scene=''>  | + | <StructureSection load='3g4g' size='340' side='right'caption='[[3g4g]], [[Resolution|resolution]] 2.30Å' scene=''>  | 
== Structural highlights ==  | == Structural highlights ==  | ||
| - | <table><tr><td colspan='2'>[[3g4g]] is a 4 chain structure with sequence from [  | + | <table><tr><td colspan='2'>[[3g4g]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3G4G OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3G4G FirstGlance]. <br>  | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=D71:1-(3-NITROPHENYL)-3-(PYRIDIN-4-YLMETHYL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE'>D71</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>  | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=D71:1-(3-NITROPHENYL)-3-(PYRIDIN-4-YLMETHYL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE'>D71</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>  | 
| - | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3g45|3g45]], [[3g4i|3g4i]], [[3g4k|3g4k]], [[3g4l|3g4l]], [[3g58|3g58]], [[3gpz|3gpz]]</td></tr>  | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[3g45|3g45]], [[3g4i|3g4i]], [[3g4k|3g4k]], [[3g4l|3g4l]], [[3g58|3g58]], [[3gpz|3gpz]]</div></td></tr>  | 
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PDE4D, DPDE3 ([  | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PDE4D, DPDE3 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>  | 
| - | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[  | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/3',5'-cyclic-nucleotide_phosphodiesterase 3',5'-cyclic-nucleotide phosphodiesterase], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.17 3.1.4.17] </span></td></tr>  | 
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[  | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3g4g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3g4g OCA], [https://pdbe.org/3g4g PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3g4g RCSB], [https://www.ebi.ac.uk/pdbsum/3g4g PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3g4g ProSAT]</span></td></tr>  | 
</table>  | </table>  | ||
== Disease ==  | == Disease ==  | ||
| - | [[  | + | [[https://www.uniprot.org/uniprot/PDE4D_HUMAN PDE4D_HUMAN]] Note=Genetic variations in PDE4D might be associated with susceptibility to stroke. PubMed:17006457 states that association with stroke has to be considered with caution.  Defects in PDE4D are the cause of acrodysostosis type 2, with or without hormone resistance (ACRDYS2) [MIM:[https://omim.org/entry/614613 614613]]. ACRDYS2 is a pleiotropic disorder characterized by skeletal, endocrine, and neurological abnormalities. Skeletal features include brachycephaly, midface hypoplasia with a small upturned nose, brachydactyly, and lumbar spinal stenosis. Endocrine abnormalities include hypothyroidism and hypogonadism in males and irregular menses in females. Developmental disability is a common finding but is variable in severity and can be associated with significant behavioral problems.<ref>PMID:22464250</ref>    | 
== Function ==  | == Function ==  | ||
| - | [[  | + | [[https://www.uniprot.org/uniprot/PDE4D_HUMAN PDE4D_HUMAN]] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.<ref>PMID:15260978</ref> <ref>PMID:15576036</ref>    | 
== Evolutionary Conservation ==  | == Evolutionary Conservation ==  | ||
[[Image:Consurf_key_small.gif|200px|right]]  | [[Image:Consurf_key_small.gif|200px|right]]  | ||
Check<jmol>  | Check<jmol>  | ||
  <jmolCheckbox>  |   <jmolCheckbox>  | ||
| - |     <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/g4/3g4g_consurf.spt"</scriptWhenChecked>  | + |     <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/g4/3g4g_consurf.spt"</scriptWhenChecked>  | 
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>  |     <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>  | ||
    <text>to colour the structure by Evolutionary Conservation</text>  |     <text>to colour the structure by Evolutionary Conservation</text>  | ||
| Line 33: | Line 33: | ||
</div>  | </div>  | ||
<div class="pdbe-citations 3g4g" style="background-color:#fffaf0;"></div>  | <div class="pdbe-citations 3g4g" style="background-color:#fffaf0;"></div>  | ||
| + | |||
| + | ==See Also==  | ||
| + | *[[Phosphodiesterase 3D structures|Phosphodiesterase 3D structures]]  | ||
== References ==  | == References ==  | ||
<references/>  | <references/>  | ||
| Line 39: | Line 42: | ||
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]]  | [[Category: 3',5'-cyclic-nucleotide phosphodiesterase]]  | ||
[[Category: Human]]  | [[Category: Human]]  | ||
| + | [[Category: Large Structures]]  | ||
[[Category: Staker, B L]]  | [[Category: Staker, B L]]  | ||
[[Category: Alternative splicing]]  | [[Category: Alternative splicing]]  | ||
Revision as of 07:55, 9 March 2022
Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871
  | |||||||||||

